Rare Disease Day 2021
February 22, 2021 |
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to distract from awareness generated by patient groups.
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to distract from awareness generated by patient groups.
In fact, we want to offer our platform to amplify the voices of the rare disease community and we will be sharing Rare Disease Day-related content during this period. So, if you are part of a patient group and would like us to share your posts, please tag #Share4Rare and we will happily share to our network.
We recognise the importance of this day for rare disease patient groups in supporting their communities and raising awareness, and it’s for this reason that OPEN Health is saying “Shhhh” on Rare Disease Day 2021!
If you would like to understand more about our commitment, capabilities and experience in rare disease please contact:
Gavin Jones, Global Advisor, Rare Diseases
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health Appoints Tim Perryman as Global Head of Operations to Strengthen Operational Excellence and Support Global Growth
OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients…
OPEN Health Appoints Peter Black as EVP, Global Client Partner and Transformation Lead to Accelerate Global Client Partnerships and Digital Innovation
OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.
OPEN Health Appoints Cara Priest as Chief People Officer to Strengthen Culture, Capability and Organisational Performance
OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.
OPEN Health Appoints Matt D’Auria as Chief Executive Officer to Drive Innovation and Growth
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of…
OPEN Health Appoints David Sakadelis as Chief Technology Officer
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for…
The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy
Discover the key takeaways from OPEN Health’s latest whitepaper: “The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy.”
OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development
OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward…
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine…
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer